APA (7th ed.) Citation

A, P., X, L., S, C., A, B., A, L., A, K., . . . I, S. (2024). Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients. Frontiers in immunology, 15, 1352330. https://doi.org/10.3389/fimmu.2024.1352330

Chicago Style (17th ed.) Citation

A, Pérez-Díez, et al. "Prevalence of Anti-lymphocyte IgM Autoantibodies Driving Complement Activation in COVID-19 Patients." Frontiers in Immunology 15 (2024): 1352330. https://doi.org/10.3389/fimmu.2024.1352330.

MLA (9th ed.) Citation

A, Pérez-Díez, et al. "Prevalence of Anti-lymphocyte IgM Autoantibodies Driving Complement Activation in COVID-19 Patients." Frontiers in Immunology, vol. 15, 2024, p. 1352330, https://doi.org/10.3389/fimmu.2024.1352330.